ABALOPARATIDE
Information current as at: 1 October 2025
Submission Details
- Brand name:
-
- Eladynos®
- Pharmaceutical company:
- THERAMEX AUSTRALIA PTY LTD
- Condition/indication:
(therapeutic use) -
- Osteoporosis
- PBAC Submission type:
- New PBS listing (–)
- Comment:
- --
- Public Summary Document:
- Not yet available
- Related medicines:
- --
Progress Details
-
Submission received for: - July 2025 PBAC meeting
-
Opportunity for consumer comment: - Open 02/04/2025 and close 28/05/2025 (see PBS Website)
-
PBAC meeting: - Held on 09/07/2025
-
PBAC outcome published: - Recommended (see PBAC Outcomes)
-
Notice of intent submitted:
- Awaiting lodgement from pharmaceutical company
-
5Lodgement of required documentation:
-
6Agreement to listing arrangements:
- Has not yet commenced
-
7Government processes:
- Has not yet commenced
-
8Medicine listed on the PBS:
- Has not yet occurred
Case ID: a1043
Page last updated: 31 August 2025